(2015). Editorial commentary: Linezolid vs daptomycin for vancomycin-resistant enterococci: the evidence gap between trials and clinical experience.
Chicago Style (17th ed.) CitationEditorial Commentary: Linezolid Vs Daptomycin for Vancomycin-resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience. 2015.
MLA (8th ed.) CitationEditorial Commentary: Linezolid Vs Daptomycin for Vancomycin-resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience. 2015.
Warning: These citations may not always be 100% accurate.